Boston Scientific Corp (BSX)

$61.86 -0.73 (-1.17%)
Market Cap 93.02B
Revenue (ttm) 20.07B
Net Income (ttm) 2.90B
EPS (ttm) N/A
PE Ratio 20.60
Forward PE 18.20
Profit Margin 14.44%
Debt to Equity Ratio 0.47
Volume 18,325,161
Avg Vol 17,148,166
Day's Range N/A - N/A
Shares Out 1.49B
Stochastic %K 9%
Beta 0.78
Analysts Strong Sell
Price Target $103.20

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary syst...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 683 4000
Address:
300 Boston Scientific Way, Marlborough, United States
toro7
toro7 Apr. 8 at 2:20 PM
$BSX will we ever get above $63?? šŸ˜‚
0 Ā· Reply
TannerSwings
TannerSwings Apr. 8 at 1:15 PM
$BSX $FRSH $UPS $FISV '
0 Ā· Reply
_TannerPicks
_TannerPicks Apr. 8 at 12:30 PM
$GE $BSX $AVAV $CNQ bb
1 Ā· Reply
DragonAlgo
DragonAlgo Apr. 8 at 10:50 AM
šŸ‰ $BSX CALL ā€” DragonAlgoĀ® Signal Contract: BSX CALL Expiry: 2026-04-10 | Strike: $61.00 | Type: CALL Option Plan (premium): Entry: $1.35 Stop: $0.97 TP1: $1.76 TP2: $2.29 TP3: $3.24 šŸ”— https://dragonalgo.com
0 Ā· Reply
stilluminati
stilluminati Apr. 8 at 1:55 AM
$BSX PR Newswire: $BSX BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit Full analysis ā†’ https://www.stockilluminati.com/bsx/news.php !
0 Ā· Reply
Fresher
Fresher Apr. 8 at 12:21 AM
$BSX letā€™s see how much it can bounce with market tomorrowā€¦
0 Ā· Reply
DLH1978
DLH1978 Apr. 7 at 11:40 PM
$BSX hit with some news first thing in the morning. And send it
0 Ā· Reply
DragonAlgo
DragonAlgo Apr. 7 at 5:10 PM
šŸ‰ $BSX PUT ā€” DragonAlgoĀ® Signal Contract: BSX PUT Expiry: 2026-04-10 | Strike: $63.00 | Type: PUT Option Plan (premium): Entry: $1.98 Stop: $1.42 TP1: $2.57 TP2: $3.36 TP3: $4.74 šŸ”— https://dragonalgo.com
0 Ā· Reply
toro7
toro7 Apr. 7 at 5:09 PM
$BSX great entry. Monthly RSI close to 20.
0 Ā· Reply
topstockalerts
topstockalerts Apr. 7 at 4:48 PM
5 stocks in the S&P 500 trade at new 52-week lows On Tuesday, five stocks in the S&P 500 traded at new 52-week lows. Tickers that hit this milestone included: Home Depot trading at lows not seen since December 2023 Nike trading at lows not seen since October 2014 Boston Scientific trading at lows not seen since January 2024 Insulet trading at lows not seen since August 2024 Axon Enterprise trading at lows not seen since September 2024 $HD $NKE $BSX $AXON
0 Ā· Reply
Latest News on BSX
BSX Stockholders Have Rights ā€“ If You Lost Money Investing in Boston Scientific Corporation Contact Robbins LLP for Information About Recovering Your Losses

Mar 31, 2026, 3:08 PM EDT - 7 days ago

BSX Stockholders Have Rights ā€“ If You Lost Money Investing in Boston Scientific Corporation Contact Robbins LLP for Information About Recovering Your Losses

Boston Scientific Drops Despite Encouraging Trial Readouts

Mar 30, 2026, 12:44 PM EDT - 8 days ago

Boston Scientific Drops Despite Encouraging Trial Readouts

Boston Scientific announces conference call discussing first quarter 2026 results

Mar 30, 2026, 8:00 AM EDT - 9 days ago

Boston Scientific announces conference call discussing first quarter 2026 results

CHAMPION-AF study of the WATCHMAN FLXā„¢ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

Mar 28, 2026, 10:55 AM EDT - 11 days ago

CHAMPION-AF study of the WATCHMAN FLXā„¢ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

HI-PEITHO trial demonstrates Boston Scientific EKOSā„¢ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

Mar 28, 2026, 10:38 AM EDT - 11 days ago

HI-PEITHO trial demonstrates Boston Scientific EKOSā„¢ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

Mar 12, 2026, 9:00 AM EDT - 27 days ago

BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

8 Stocks to Buy as Merger-Mania Takes Over

Mar 10, 2026, 12:42 PM EDT - 4 weeks ago

8 Stocks to Buy as Merger-Mania Takes Over

AVTR EPC ITGR MXL PEN POWI PRGO

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

Mar 8, 2026, 8:24 PM EDT - 4 weeks ago

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Mar 6, 2026, 1:56 PM EST - 4 weeks ago

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

Mar 6, 2026, 8:00 AM EST - 4 weeks ago

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

Boston Scientific Corporation Investigated by the Portnoy Law Firm

Mar 4, 2026, 9:00 AM EST - 5 weeks ago

Boston Scientific Corporation Investigated by the Portnoy Law Firm

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 25, 2026, 1:00 PM EST - 5 weeks ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

PEN

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Feb 23, 2026, 8:00 AM EST - 6 weeks ago

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Back on the Radar: Prior Picks Offer Fresh Opportunity

Feb 18, 2026, 10:47 AM EST - 7 weeks ago

Back on the Radar: Prior Picks Offer Fresh Opportunity

NFLX

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Feb 13, 2026, 8:00 AM EST - 7 weeks ago

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Reassessing The Boston Scientific Bull Thesis

Feb 6, 2026, 2:05 PM EST - 2 months ago

Reassessing The Boston Scientific Bull Thesis

What Happened To Boston Scientific Stock?

Feb 5, 2026, 2:25 PM EST - 2 months ago

What Happened To Boston Scientific Stock?

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Feb 5, 2026, 8:18 AM EST - 2 months ago

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Feb 4, 2026, 9:19 AM EST - 2 months ago

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Feb 4, 2026, 8:12 AM EST - 2 months ago

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Boston Scientific shares slide on cautious 2026 revenue forecast

Feb 4, 2026, 8:02 AM EST - 2 months ago

Boston Scientific shares slide on cautious 2026 revenue forecast

Boston Scientific announces results for fourth quarter and full year 2025

Feb 4, 2026, 6:30 AM EST - 2 months ago

Boston Scientific announces results for fourth quarter and full year 2025

PEN

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 4, 2026, 2:02 AM EST - 2 months ago

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq ā€“ RAPT), Penumbra, Inc. (NYSE ā€“ PEN), Calavo Growers, Inc. (Nasdaq ā€“ CVGW), FONAR Corporation (Nasdaq - FONR)

Feb 2, 2026, 5:02 PM EST - 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq ā€“ RAPT), Penumbra, Inc. (NYSE ā€“ PEN), Calavo Growers, Inc. (Nasdaq ā€“ CVGW), FONAR Corporation (Nasdaq - FONR)

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

Jan 26, 2026, 2:54 PM EST - 2 months ago

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

APP CMI MNST WYNN

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Jan 16, 2026, 10:00 AM EST - 2 months ago

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE ā€“ PEN), Calavo Growers, Inc. (Nasdaq ā€“ CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Jan 15, 2026, 11:03 AM EST - 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE ā€“ PEN), Calavo Growers, Inc. (Nasdaq ā€“ CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

Jan 15, 2026, 9:11 AM EST - 2 months ago

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

PEN

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

Jan 15, 2026, 8:45 AM EST - 2 months ago

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

PEN

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ā€˜fast-growing' vascular segments

Jan 15, 2026, 8:11 AM EST - 2 months ago

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ā€˜fast-growing' vascular segments

PEN

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

Jan 15, 2026, 7:19 AM EST - 2 months ago

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

PEN

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

Jan 15, 2026, 7:07 AM EST - 2 months ago

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

PEN

Boston Scientific announces agreement to acquire Penumbra, Inc.

Jan 15, 2026, 7:00 AM EST - 2 months ago

Boston Scientific announces agreement to acquire Penumbra, Inc.

PEN

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 12, 2026, 7:00 AM EST - 3 months ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Jan 2, 2026, 8:00 AM EST - 3 months ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Boston Scientific announces upcoming investor conference schedule

Nov 3, 2025, 8:00 AM EST - 5 months ago

Boston Scientific announces upcoming investor conference schedule

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Oct 23, 2025, 9:41 AM EDT - 5 months ago

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Oct 22, 2025, 7:36 AM EDT - 6 months ago

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Oct 22, 2025, 6:59 AM EDT - 6 months ago

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

toro7
toro7 Apr. 8 at 2:20 PM
$BSX will we ever get above $63?? šŸ˜‚
0 Ā· Reply
TannerSwings
TannerSwings Apr. 8 at 1:15 PM
$BSX $FRSH $UPS $FISV '
0 Ā· Reply
_TannerPicks
_TannerPicks Apr. 8 at 12:30 PM
$GE $BSX $AVAV $CNQ bb
1 Ā· Reply
DragonAlgo
DragonAlgo Apr. 8 at 10:50 AM
šŸ‰ $BSX CALL ā€” DragonAlgoĀ® Signal Contract: BSX CALL Expiry: 2026-04-10 | Strike: $61.00 | Type: CALL Option Plan (premium): Entry: $1.35 Stop: $0.97 TP1: $1.76 TP2: $2.29 TP3: $3.24 šŸ”— https://dragonalgo.com
0 Ā· Reply
stilluminati
stilluminati Apr. 8 at 1:55 AM
$BSX PR Newswire: $BSX BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit Full analysis ā†’ https://www.stockilluminati.com/bsx/news.php !
0 Ā· Reply
Fresher
Fresher Apr. 8 at 12:21 AM
$BSX letā€™s see how much it can bounce with market tomorrowā€¦
0 Ā· Reply
DLH1978
DLH1978 Apr. 7 at 11:40 PM
$BSX hit with some news first thing in the morning. And send it
0 Ā· Reply
DragonAlgo
DragonAlgo Apr. 7 at 5:10 PM
šŸ‰ $BSX PUT ā€” DragonAlgoĀ® Signal Contract: BSX PUT Expiry: 2026-04-10 | Strike: $63.00 | Type: PUT Option Plan (premium): Entry: $1.98 Stop: $1.42 TP1: $2.57 TP2: $3.36 TP3: $4.74 šŸ”— https://dragonalgo.com
0 Ā· Reply
toro7
toro7 Apr. 7 at 5:09 PM
$BSX great entry. Monthly RSI close to 20.
0 Ā· Reply
topstockalerts
topstockalerts Apr. 7 at 4:48 PM
5 stocks in the S&P 500 trade at new 52-week lows On Tuesday, five stocks in the S&P 500 traded at new 52-week lows. Tickers that hit this milestone included: Home Depot trading at lows not seen since December 2023 Nike trading at lows not seen since October 2014 Boston Scientific trading at lows not seen since January 2024 Insulet trading at lows not seen since August 2024 Axon Enterprise trading at lows not seen since September 2024 $HD $NKE $BSX $AXON
0 Ā· Reply
Fresher
Fresher Apr. 7 at 4:16 PM
$BSX started heavy [email protected].. will trim if we go up after earnings
0 Ā· Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Apr. 7 at 3:27 PM
$BSX bottom fishing to build position at these levels
0 Ā· Reply
HoggMcCrankin
HoggMcCrankin Apr. 7 at 2:23 PM
$BSX god damn this is an abysmal stock
0 Ā· Reply
TeresaTrades
TeresaTrades Apr. 7 at 1:42 PM
Largest CALL OI decreases $UAL $XOM $WIX $NOK $BSX
0 Ā· Reply
stilluminati
stilluminati Apr. 7 at 5:15 AM
$BSX GlobeNewsWire: $BSX ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important... Full analysis ā†’ https://www.stockilluminati.com/bsx/news.php .
0 Ā· Reply
DragonAlgo
DragonAlgo Apr. 6 at 10:49 PM
šŸ‰ $BSX CALL ā€” DragonAlgoĀ® Signal Contract: BSX CALL Expiry: 2026-04-10 | Strike: $62.00 | Type: CALL Option Plan (premium): Entry: $1.38 Stop: $0.99 TP1: $1.79 TP2: $2.34 TP3: $3.30 šŸ”— https://dragonalgo.com
0 Ā· Reply
DLH1978
DLH1978 Apr. 6 at 10:48 PM
$BSX itā€™s that time
0 Ā· Reply
HoggMcCrankin
HoggMcCrankin Apr. 6 at 9:19 PM
$BSX does the upward Medicare rate adjustments help this POS?
1 Ā· Reply
Probably_Drunk
Probably_Drunk Apr. 6 at 6:36 PM
$BSX Does this ever have green days anymore? Or we just go closer to zero every day....
1 Ā· Reply
HoggMcCrankin
HoggMcCrankin Apr. 6 at 3:29 PM
$BSX wtf is wrong with this POS
0 Ā· Reply
have_to_gain
have_to_gain Apr. 5 at 1:25 PM
$BSX want to add 5k $ is this good price around here and wait long?
1 Ā· Reply
Treadwater
Treadwater Apr. 4 at 9:57 PM
$BSX Itā€™s going up Lead Pipe Cinch
1 Ā· Reply